Latest updates for Acquired Hemophilia

Fresh curated links around acquired hemophilia are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Simple clotting tests may help speed diagnosis of acquired hemophilia A
  • Clotting factor inhibitors in hemophilia A
  • Symptoms of hemophilia A

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hemophilianewstoday.com /3 weeks ago

Simple clotting tests may help speed diagnosis of acquired hemophilia A

Recognizing acquired hemophilia A (AHA) early and ordering simple blood clotting tests in older patients with unexplained bruising or anemia — a low number of red blood cells — may...

Read source
hemophilianewstoday.com /1 month ago

Clotting factor inhibitors in hemophilia A

Hemophilia A is a bleeding disorder caused by a deficiency in the blood-clotting factor VIII (FVIII) protein. Standard treatment usually relies on factor replacement therapy, which...

Read source
hemophilianewstoday.com /1 month ago

Symptoms of hemophilia A

Hemophilia A is a rare inherited bleeding disorder and the most common type of hemophilia, accounting for about 80% of cases. It is caused by mutations in the F8 gene that lead to...

Read source
hemophilianewstoday.com /1 month ago

Hemophilia A in women

Hemophilia A, a genetic bleeding disorder, is often underdiagnosed in women because of the historical misconception that it affects only men due to its inheritance pattern. While w...

Read source
hemophilianewstoday.com /1 month ago

How is hemophilia A inherited?

Hemophilia A, the most common type of hemophilia, is a bleeding disorder that is inherited in an X-linked, recessive manner. This is because the F8 gene, which can cause hemophilia...

Read source
hemophilianewstoday.com /2 days ago

Obizur (susoctocog alfa) for hemophilia

Obizur (susoctocog alfa) is a recombinant porcine (pig-derived) factor VIII concentrate approved for the on-demand treatment of bleeds in adults with acquired hemophilia A. The pos...

Read source
hemophilianewstoday.com /1 month ago

Hemophilia A treatment

There is no cure for hemophilia A, but several treatments are available to help prevent and control bleeds, reduce the risk of complications, and improve quality of life. People wi...

Read source
hemophilianewstoday.com /1 month ago

Factor VIII replacement therapy for hemophilia A

Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a prot...

Read source
hemophilianewstoday.com /3 days ago

Preventive treatment may cut hospital costs for acquired hemophilia

Upfront treatment with Hemlibra (emicizumab-KXWH) may help reduce hospitalization costs associated with treating bleeds in older adults with acquired hemophilia A (AHA), according...

Read source
hemophilianewstoday.com /3 days ago

Hemophilia symptoms

Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged pe...

Read source
hemophilianewstoday.com /2 weeks ago

Hemophilia As an Inherited Disorder

Inside hemophilia genetics, such as F8 and F9 mutations, inheritance patterns, and de novo variants. Plus, evolving approaches to females with hemophilia. The post Hemophilia As an...

Read source
hemophilianewstoday.com /3 weeks ago

Long-lasting hemophilia treatment may offer hope in hard-to-treat cases

Once-weekly infusions of Altuvoct (efanesoctocog alfa) — a long-lasting hemophilia treatment marketed in the U.S. as Altuviiio — reduced bleeding in adults and children with hemoph...

Read source
hemophilianewstoday.com /2 weeks ago

Approved treatment controls bleeding for up to 5 years in hemophilia A

Long-term treatment with Hemlibra (emicizumab) provided sustained protection against bleeding for up to five years in people with hemophilia A, with no new safety concerns identifi...

Read source
hemophilianewstoday.com /2 weeks ago

Bleeding Response in Hemophilia

A look at how FVIII/FIX deficiency contributes to variable disease severity and provides the biologic foundation for modern hemophilia therapies. The post Bleeding Response in Hemo...

Read source
hemophilianewstoday.com /2 weeks ago

Management Challenges in Hemophilia: From Delayed Bleeding to Chronic Injury

Factor deficiencies can disrupt clot formation, causing bleeding complications, arthropathy, the development of inhibitors, and long-term disease burden. The post Management Challe...

Read source
hemophilianewstoday.com /2 weeks ago

Hemophilia Management: Emergency Stabilization and Long-Term Strategies

From acute bleeds and inhibitor considerations to long-term approaches. The post Hemophilia Management: Emergency Stabilization and Long-Term Strategies appeared first on Hemophili...

Read source
hemophilianewstoday.com /1 month ago

Hemophilia A treatments may shape children’s immune responses

In a small study, children with hemophilia A had distinct changes in certain immune cells and inflammatory signaling molecules compared with healthy children, and the type of preve...

Read source
hemophilianewstoday.com /3 days ago

Rebinyn (nonacog beta pegol) for hemophilia

Rebinyn (nonacog beta pegol) is a recombinant factor IX concentrate used to prevent and treat bleeds, including those occurring during surgery, in children and adults with hemophil...

Read source
hemophilianewstoday.com /1 month ago

Guest Voice: Using hemophilia pain and tribulation to lift others up

Having severe hemophilia A means everything can be life-threatening. In February, I had a tooth extraction that required sedation, after a year of preparation. It took that long be...

Read source
hemophilianewstoday.com /1 month ago

Experimental treatment maintains low bleed rates in hemophilia A

Denecimig (Mim8), an investigational antibody therapy being developed by Novo Nordisk, continued to maintain low bleeding rates in children, adolescents, and adults with hemophilia...

Read source
hemophilianewstoday.com /6 days ago

Switching clotting factor products doesn’t lead to new inhibitors

Switching clotting factor products did not cause new inhibitors (neutralizing antibodies that can prevent the treatment from working) to develop in previously treated patients with...

Read source
hemophilianewstoday.com /2 weeks ago

Gene and Disease-Modifying Therapies for Hemophilia

Inside the evolving hemophilia treatment landscape, including AAV-based gene therapies, non-factor prophylaxis, and approaches that aim to reduce treatment burden. The post Gene an...

Read source
hemophilianewstoday.com /2 weeks ago

How inhibitors complicate hemophilia management

Shannon Walker, MD, explains the importance of inhibitor screening and how newer hemophilia treatments may affect inhibitor development. The post How inhibitors complicate hemophil...

Read source
hemophilianewstoday.com /1 month ago

Many women with hemophilia face heavy symptoms and care gaps

Although it’s often mistakenly thought of as a male disease, hemophilia affects a substantial number of women and girls, manifesting with symptoms that can include heavy menstrual...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Acquired Hemophilia

hemophilianewstoday.com

Recent coverage from public sources
Public source